Sponsor overview

Jiangsu Cancer Institute & Hospital

Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.

Back to report

Summary

Signal counts

Assets tracked: 1

Watchlist assets: 1

Registry stop assets: 0

Evidence links

Public sources

https://clinicaltrials.gov/study/NCT05417230 | https://clinicaltrials.gov/study/NCT05135715 | https://clinicaltrials.gov/study/NCT03500380 | https://clinicaltrials.gov/study/NCT05297552 | https://clinicaltrials.gov/study/NCT05996952 | https://clinicaltrials.gov/study/NCT06178601 | https://clinicaltrials.gov/study/NCT04073602

Assets

Linked programs

RC48-ADC: Timeline Staleness Signal (5/5)